Bruker Corporation (BRKR) Financials
BRKR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 3.8 billion | 2.6 billion |
2023-06-30 | 3.9 billion | 2.6 billion |
2023-03-31 | 3.8 billion | 2.6 billion |
2022-12-31 | 3.6 billion | 2.5 billion |
BRKR Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 17.2 million | 5.7 million |
2023-06-30 | -10.5 million | 5.6 million |
2023-03-31 | 62.5 million | 5.3 million |
2022-12-31 | 134.7 million | 4.7 million |
BRKR Net Income
Date | Net Income |
---|---|
2023-09-30 | 88.7 million |
2023-06-30 | 57.8 million |
2023-03-31 | 77.4 million |
2022-12-31 | 98.3 million |
BRKR Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 363.6 million | - | - |
2023-06-30 | 574.8 million | - | - |
2023-03-31 | 597.9 million | 1.1 billion | - |
2022-12-31 | 645.5 million | 1.2 billion | 51.2 million |
BRKR Shares Outstanding
BRKR Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 26.9 million | 71.3 million | 177.6 million | - |
2023-06-30 | 23.5 million | 71.0 million | 177.9 million | - |
2023-03-31 | 25.0 million | 69.0 million | 162.7 million | - |
2022-12-31 | 24.4 million | 63.5 million | 168.1 million | 3.4 million |
BRKR Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 742.8 million | 360.0 million |
2023-06-30 | 681.9 million | 341.4 million |
2023-03-31 | 685.3 million | 325.6 million |
2022-12-31 | 708.4 million | 342.5 million |
BRKR
Price: $77.78
Dividend Yield: 0.00%
Forward Dividend Yield: 0.25%
Payout Ratio: 9.26%
Dividend Per Share: 0.20 USD
Earnings Per Share: 2.90 USD
P/E Ratio: 32.62
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 459000
Ebitda: 109.4 millionMarket Capitalization: 12.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 9
DGR3: 8.83%
DGR5: 5.30%